Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 238

1.

Characterization of pharmacist-based medication management services in a community pharmacy.

Salmasi S, Tsao NW, Li K, Shaske JN, Marra CA, Lynd LD.

Res Social Adm Pharm. 2019 Apr 25. pii: S1551-7411(19)30445-0. doi: 10.1016/j.sapharm.2019.04.051. [Epub ahead of print]

PMID:
31060791
2.

Inhaled corticosteroids and the risk of lung cancer in COPD: a population-based cohort study.

Raymakers AJN, Sadatsafavi M, Sin DD, FitzGerald JM, Marra CA, Lynd LD.

Eur Respir J. 2019 Jun 5;53(6). pii: 1801257. doi: 10.1183/13993003.01257-2018. Print 2019 Jun.

PMID:
30956205
3.

Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis.

Donnan JR, Grandy CA, Chibrikov E, Marra CA, Aubrey-Bassler K, Johnston K, Swab M, Hache J, Curnew D, Nguyen H, Gamble JM.

BMJ Open. 2019 Feb 1;9(1):e022577. doi: 10.1136/bmjopen-2018-022577.

4.

Perspectives of Patients with Multiple Sclerosis on Drug Treatment: A Qualitative Study.

Lynd LD, Henrich NJ, Hategeka C, Marra CA, Mittmann N, Evans C, Traboulsee AL.

Int J MS Care. 2018 Nov-Dec;20(6):269-277. doi: 10.7224/1537-2073.2017-109.

5.

Pro-apoptotic effects of low doses of dimethoate in rat brain.

Arnal N, Morel G, Marra CA, Astiz M.

Toxicol Appl Pharmacol. 2019 Jan 15;363:57-63. doi: 10.1016/j.taap.2018.11.013. Epub 2018 Nov 28.

PMID:
30502393
6.

How do parents and providers trade-off between disability and survival? Preferences in the treatment of pediatric medulloblastoma.

Khakban A, Mohammadi T, Lynd LD, Mabbott DJ, Bouffet E, Gastonguay L, Zafari Z, Malkin D, Taylor MD, Marra CA.

Patient Prefer Adherence. 2018 Oct 10;12:2103-2110. doi: 10.2147/PPA.S168739. eCollection 2018.

7.

Exploring strategies to support medication adherence in patients with inflammatory arthritis: a patient-oriented qualitative study using an interactive focus group activity.

Rai SK, Howren A, Wilcox ES, Townsend AF, Marra CA, Aviña-Zubieta JA, De Vera MA.

Patient Prefer Adherence. 2018 Oct 5;12:2015-2025. doi: 10.2147/PPA.S174672. eCollection 2018.

8.

Incremental direct medical costs of systemic lupus erythematosus patients in the years preceding diagnosis: A general population-based study.

McCormick N, Marra CA, Sadatsafavi M, Aviña-Zubieta JA.

Lupus. 2018 Jul;27(8):1247-1258. doi: 10.1177/0961203318768882. Epub 2018 Apr 17.

PMID:
29665755
9.

Excess Productivity Costs of Systemic Lupus Erythematosus, Systemic Sclerosis, and Sjögren's Syndrome: A General Population-Based Study.

McCormick N, Marra CA, Sadatsafavi M, Kopec JA, Aviña-Zubieta JA.

Arthritis Care Res (Hoboken). 2019 Jan;71(1):142-154. doi: 10.1002/acr.23573.

PMID:
29648677
10.

Risk of preterm delivery and small-for-gestational-age births in women with autoimmune disease using biologics before or during pregnancy: a population-based cohort study.

Tsao NW, Sayre EC, Hanley G, Sadatsafavi M, Lynd LD, Marra CA, De Vera MA.

Ann Rheum Dis. 2018 Jun;77(6):869-874. doi: 10.1136/annrheumdis-2018-213023. Epub 2018 Mar 1.

PMID:
29496718
11.

Productivity Losses and Costs in the Less-Common Systemic Autoimmune Rheumatic Diseases.

McCormick N, Marra CA, Aviña-Zubieta JA.

Curr Rheumatol Rep. 2017 Oct 30;19(11):72. doi: 10.1007/s11926-017-0698-9. Review.

PMID:
29086172
12.

The validity of the SF-12 and SF-6D instruments in people living with HIV/AIDS in Kenya.

Patel AR, Lester RT, Marra CA, van der Kop ML, Ritvo P, Engel L, Karanja S, Lynd LD.

Health Qual Life Outcomes. 2017 Jul 17;15(1):143. doi: 10.1186/s12955-017-0708-7.

13.

Testing the External Validity of a Discrete Choice Experiment Method: An Application to Latent Tuberculosis Infection Treatment.

Mohammadi T, Bansback N, Marra F, Khakban A, Campbell JR, FitzGerald JM, Lynd LD, Marra CA.

Value Health. 2017 Jul - Aug;20(7):969-975. doi: 10.1016/j.jval.2017.04.007. Epub 2017 May 19.

15.

A philosophical framework for pharmacy in the 21st century guided by ethical principles.

Duffull SB, Wright DFB, Marra CA, Anakin MG.

Res Social Adm Pharm. 2018 Mar;14(3):309-316. doi: 10.1016/j.sapharm.2017.04.049. Epub 2017 Apr 28.

16.

Consumer preferences for food allergen labeling.

Marra CA, Harvard S, Grubisic M, Galo J, Clarke A, Elliott S, Lynd LD.

Allergy Asthma Clin Immunol. 2017 Apr 4;13:19. doi: 10.1186/s13223-017-0189-6. eCollection 2017.

17.

Opinions and preferences of British Columbia pharmacists and physicians on medication management services.

Tsao NW, Khakban A, Gastonguay L, Zafari Z, Lynd LD, Marra CA.

Can Pharm J (Ott). 2016 Oct 12;150(1):42-51. doi: 10.1177/1715163516671746. eCollection 2017 Jan-Feb.

18.

Economic evaluation of mobile phone text message interventions to improve adherence to HIV therapy in Kenya.

Patel AR, Kessler J, Braithwaite RS, Nucifora KA, Thirumurthy H, Zhou Q, Lester RT, Marra CA.

Medicine (Baltimore). 2017 Feb;96(7):e6078. doi: 10.1097/MD.0000000000006078.

19.

Societal preferences in the treatment of pediatric medulloblastoma: Balancing risk of death and quality of life.

Khakban A, Mohammadi T, Lynd LD, Mabbott D, Bouffet E, Gastonguay L, Zafari Z, Malkin D, Taylor M, Marra CA.

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26340. Epub 2016 Dec 4.

PMID:
27917595
20.

Excess medical costs in patients with asthma and the role of comorbidity.

Chen W, Lynd LD, FitzGerald JM, Marra CA, Balshaw R, To T, Tavakoli H, Sadatsafavi M; Canadian Respiratory Research Network.

Eur Respir J. 2016 Dec;48(6):1584-1592. doi: 10.1183/13993003.01141-2016. Epub 2016 Oct 6.

21.

Do inhaled corticosteroids protect against lung cancer in patients with COPD? A systematic review.

Raymakers AJ, McCormick N, Marra CA, Fitzgerald JM, Sin D, Lynd LD.

Respirology. 2017 Jan;22(1):61-70. doi: 10.1111/resp.12919. Epub 2016 Oct 19. Review.

22.

Health State Utilities and Disease Duration in Systemic Sclerosis: Is There an Association?

Raymakers AJ, Tsao NW, Marra CA, Clements PJ, Khanna D.

J Rheumatol. 2016 Oct;43(10):1832-1837. Epub 2016 Aug 1.

23.

Quantitative analysis of multiple sclerosis patients' preferences for drug treatment: a best-worst scaling study.

Lynd LD, Traboulsee A, Marra CA, Mittmann N, Evans C, Li KH, Carter M, Hategekimana C.

Ther Adv Neurol Disord. 2016 Jul;9(4):287-96. doi: 10.1177/1756285616648060. Epub 2016 May 15.

24.

The Impact of Price-cap Regulations on Exit by Generic Pharmaceutical Firms.

Zhang W, Guh D, Sun H, Marra CA, Lynd LD, Anis AH.

Med Care. 2016 Sep;54(9):884-90. doi: 10.1097/MLR.0000000000000577.

PMID:
27213540
25.

Preferences for 'New' Treatments Diminish in the Face of Ambiguity.

Harrison M, Marra CA, Bansback N.

Health Econ. 2017 Jun;26(6):743-752. doi: 10.1002/hec.3353. Epub 2016 May 12.

PMID:
27174417
26.

Are patients willing to pay for total shoulder arthroplasty? Evidence from a discrete choice experiment.

O'Hara NN, Slobogean GP, Mohammadi T, Marra CA, Vicente MR, Khakban A, McKee MD.

Can J Surg. 2016 Apr;59(2):107-12.

27.

Population-based evaluation of the effectiveness of two regimens for emergency contraception.

Leung VW, Soon JA, Lynd LD, Marra CA, Levine M.

Int J Gynaecol Obstet. 2016 Jun;133(3):342-6. doi: 10.1016/j.ijgo.2015.10.017. Epub 2016 Feb 24.

28.

Factors associated with pharmacists' perceptions of their working conditions and safety and effectiveness of patient care.

Tsao NW, Lynd LD, Gastonguay L, Li K, Nakagawa B, Marra CA.

Can Pharm J (Ott). 2016 Jan;149(1):18-27. doi: 10.1177/1715163515617777.

29.

Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma.

Zafari Z, Sadatsafavi M, Marra CA, Chen W, FitzGerald JM.

PLoS One. 2016 Jan 11;11(1):e0146003. doi: 10.1371/journal.pone.0146003. eCollection 2016.

30.

The natural history of severe asthma and influences of early risk factors: a population-based cohort study.

Chen W, Marra CA, Lynd LD, FitzGerald JM, Zafari Z, Sadatsafavi M.

Thorax. 2016 Mar;71(3):267-75. doi: 10.1136/thoraxjnl-2015-207530. Epub 2016 Jan 5.

PMID:
26732738
31.

Cognitive status is a determinant of health resource utilization among individuals with a history of falls: a 12-month prospective cohort study.

Davis JC, Dian L, Khan KM, Bryan S, Marra CA, Hsu CL, Jacova P, Chiu BK, Liu-Ambrose T.

Osteoporos Int. 2016 Mar;27(3):943-951. doi: 10.1007/s00198-015-3350-4. Epub 2015 Oct 8.

32.

Perceptions of British Columbia residents and their willingness to pay for medication management services provided by pharmacists.

Tsao NW, Khakban A, Gastonguay L, Li K, Lynd LD, Marra CA.

Can Pharm J (Ott). 2015 Sep;148(5):263-73. doi: 10.1177/1715163515597244.

33.

Dietary fats significantly influence the survival of penumbral neurons in a rat model of chronic ischemic by modifying lipid mediators, inflammatory biomarkers, NOS production, and redox-dependent apoptotic signals.

Lausada N, Arnal N, Astiz M, Marín MC, Lofeudo JM, Stringa P, Tacconi de Alaniz MJ, Tacconi de Gómez Dumm N, Hurtado de Catalfo G, Cristalli de Piñero N, Pallanza de Stringa MC, Illara de Bozzolo EM, Bozzarello EG, Cristalli DO, Marra CA.

Nutrition. 2015 Nov-Dec;31(11-12):1430-42. doi: 10.1016/j.nut.2015.05.023. Epub 2015 Jul 2.

PMID:
26429666
34.

Hepatic and intestine alterations in mice after prolonged exposure to low oral doses of Microcystin-LR.

Sedan D, Laguens M, Copparoni G, Aranda JO, Giannuzzi L, Marra CA, Andrinolo D.

Toxicon. 2015 Sep 15;104:26-33. doi: 10.1016/j.toxicon.2015.07.011. Epub 2015 Jul 23.

PMID:
26210502
35.

Healthcare Worker Preferences for Active Tuberculosis Case Finding Programs in South Africa: A Best-Worst Scaling Choice Experiment.

O'Hara NN, Roy L, O'Hara LM, Spiegel JM, Lynd LD, FitzGerald JM, Yassi A, Nophale LE, Marra CA.

PLoS One. 2015 Jul 21;10(7):e0133304. doi: 10.1371/journal.pone.0133304. eCollection 2015.

36.

Group Medical Visits (GMVs) in primary care: an RCT of group-based versus individual appointments to reduce HbA1c in older people.

Khan KM, Windt A, Davis JC, Dawes M, Liu-Ambrose T, Madden K, Marra CA, Housden L, Hoppmann C, Adams DJ.

BMJ Open. 2015 Jul 13;5(7):e007441. doi: 10.1136/bmjopen-2014-007441.

37.

Identifying relationships between the professional culture of pharmacy, pharmacists' personality traits, and the provision of advanced pharmacy services.

Rosenthal M, Tsao NW, Tsuyuki RT, Marra CA.

Res Social Adm Pharm. 2016 Jan-Feb;12(1):56-67. doi: 10.1016/j.sapharm.2015.05.003. Epub 2015 May 8.

PMID:
26050916
38.

Ten-Year Trends in Direct Costs of COPD: A Population-Based Study.

Khakban A, Sin DD, FitzGerald JM, Ng R, Zafarí Z, McManus B, Hollander Z, Marra CA, Sadatsafavi M.

Chest. 2015 Sep;148(3):640-646. doi: 10.1378/chest.15-0721.

PMID:
26043120
39.

The added effect of comorbidity on health-related quality of life in patients with asthma.

Chen W, Lynd LD, FitzGerald JM, Marra CA, Rousseau R, Sadatsafavi M.

Qual Life Res. 2015 Oct;24(10):2507-17. doi: 10.1007/s11136-015-0995-6. Epub 2015 Jun 3.

PMID:
26038225
40.

BC Medication Management Project: Perspectives of pharmacists, patients and physicians.

Henrich N, Tsao N, Gastonguay L, Lynd L, Marra CA.

Can Pharm J (Ott). 2015 Mar;148(2):90-100. doi: 10.1177/1715163515569571.

41.

Challenges in measuring the societal value of orphan drugs: insights from a canadian stated preference survey.

Dragojlovic N, Rizzardo S, Bansback N, Mitton C, Marra CA, Lynd LD.

Patient. 2015 Feb;8(1):93-101. doi: 10.1007/s40271-014-0109-5.

PMID:
25586645
42.

Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial.

De Vera MA, Sadatsafavi M, Tsao NW, Lynd LD, Lester R, Gastonguay L, Galo J, FitzGerald JM, Brasher P, Marra CA.

Trials. 2014 Dec 13;15:488. doi: 10.1186/1745-6215-15-488.

43.

Community pharmacist surveillance of hypertension in pregnancy: Are we ready for prime time?

Tsao NW, Marra CA, Lynd LD, Thomas JM, Ferreira E.

Can Pharm J (Ott). 2014 Sep;147(5):307-15. doi: 10.1177/1715163514543898.

44.

Network vs. pairwise meta-analyses: a case study of the impact of an evidence-synthesis paradigm on value of information outcomes.

Zafari Z, Thorlund K, FitzGerald JM, Marra CA, Sadatsafavi M.

Pharmacoeconomics. 2014 Oct;32(10):995-1004. doi: 10.1007/s40273-014-0179-1.

PMID:
24920194
45.

De-escalation of therapy for pediatric medulloblastoma: trade-offs between quality of life and survival.

Henrich N, Marra CA, Gastonguay L, Mabbott D, Malkin D, Fryer C, Bouffet E, Taylor MD, Hukin J, Scantlebury N, Lynd L.

Pediatr Blood Cancer. 2014 Jul;61(7):1300-4. doi: 10.1002/pbc.24990. Epub 2014 Feb 24.

PMID:
24616367
46.

Pharmacy-based Immunization in Rural Communities Strategy (PhICS): A community cluster-randomized trial.

Marra F, Kaczorowski J, Gastonguay L, Marra CA, Lynd LD, Kendall P.

Can Pharm J (Ott). 2014 Jan;147(1):33-44. doi: 10.1177/1715163513514020.

47.

Effects of Copper and/or Cholesterol Overload on Mitochondrial Function in a Rat Model of Incipient Neurodegeneration.

Arnal N, Castillo O, de Alaniz MJ, Marra CA.

Int J Alzheimers Dis. 2013;2013:645379. doi: 10.1155/2013/645379. Epub 2013 Nov 6.

48.

Cost-effectiveness of abatacept for moderate-to-severe rheumatoid arthritis.

Tsao NW, Shojania K, Marra CA.

Expert Rev Pharmacoecon Outcomes Res. 2014 Feb;14(1):9-18. doi: 10.1586/14737167.2014.861742. Epub 2013 Dec 10. Review.

PMID:
24325566
49.

Copper-induced alterations in rat brain depends on route of overload and basal copper levels.

Arnal N, Dominici L, de Tacconi MJ, Marra CA.

Nutrition. 2014 Jan;30(1):96-106. doi: 10.1016/j.nut.2013.06.009.

PMID:
24290605
50.

Role of copper and cholesterol association in the neurodegenerative process.

Arnal N, Morel GR, de Alaniz MJ, Castillo O, Marra CA.

Int J Alzheimers Dis. 2013;2013:414817. doi: 10.1155/2013/414817. Epub 2013 Oct 29.

Supplemental Content

Loading ...
Support Center